We are a patient organization for families whose children have a SYNGAP1 mutation. SYNGAP1 syndrome includes developmental disabilities, intellectual disability, epilepsy, and in 50% of cases, autism. Together, we advocate for SYNGAP and families with children with disabilities. This includes: Awareness to make the condition better known, education to enable early diagnosis, support, advice and sharing of experiences for affected families, networking with other patient organizations and researchers at home and abroad, and research funding.